IP Library Granted Patent US 11,259,825
Granted Patent B2
US 11,259,825 · App. 15/628,166 · Granted Mar 1, 2022

Devices and methods for treatment of tissue

Inventors: Robert K. Deckman (San Bruno, CA); Craig Gerbi (Mountain View, CA); Michael Munrow (Belmont, CA); Jessica Grossman (Covington, KY)
Assignee: Gynesonics, Inc.
A61B17/2256A61B8/085A61B8/0833A61B8/0841A61B8/12A61B8/44A61B8/445A61B8/4411A61B18/1477A61B18/18A61B2017/00106A61B2017/4216A61B2018/00559A61B2018/00577A61B2090/3784
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,259,825
App. No.
15/628,166
Granted
Mar 1, 2022
Kind
B2
Abstract

Delivery systems, and methods using the same, having an ultrasound viewing window for improved imaging and a needle for ablation treatment of target tissues. In an embodiment, the target tissue is a fibroid within a female's uterus. In an embodiment, the delivery system includes a rigid shaft having a proximal end, a distal end, and an axial passage extending through the rigid shaft. In an embodiment, the axial passage is configured for removably receiving the ultrasound imaging insert having an ultrasound array disposed a distal portion.

Claims (31)

1. A method of treating a uterine fibroid, said method comprising:

delivering an ultrasonic imaging device and a radiofrequency ablation device coupled together into a uterine cavity, wherein the ultrasonic imaging device comprises an ultrasonic transducer and the radiofrequency ablation device comprises one or more needle electrodes;

deflecting a distal end of the ultrasonic imaging device to orient the ultrasonic transducer;

deploying the one or more needle electrodes into a uterine fibroid while the ultrasonic imaging device provides a real time image of the uterine fibroid; and

delivering radiofrequency energy to the one or more needle electrodes.

2. The method of claim 1 , wherein the radiofrequency ablation device is contained within a sheath when delivered.

3. The method of claim 2 , wherein the one or more needle electrodes are reciprocatably advanced relative to the sheath when the one or more needle electrodes are deployed into the uterine fibroid.

4. The method of claim 3 , wherein the one or more needle electrodes are advanced laterally relative to the sheath when deployed into the uterine fibroid.

5. The method of claim 3 , wherein the one or more needle electrodes are advanced axially relative to the sheath when deployed into the uterine fibroid.

6. The method of claim 1 , wherein deploying the one or more needle electrodes into the uterine fibroid comprises advancing a plurality of needle electrodes into the uterine fibroid.

7. The method of claim 1 , wherein the one or more needle electrodes are advanced laterally relative to an access direction of the radiofrequency ablation device when the one or more needle electrodes are deployed into the uterine fibroid.

8. The method of claim 7 , wherein a plurality of needle electrodes are advanced laterally relative to an access direction of the radiofrequency ablation device when the one or more needle electrodes are deployed into the uterine fibroid.

9. The method of claim 1 , wherein the one or more needle electrodes are advanced forwardly and laterally relative to an access direction of the radiofrequency ablation device when the one or more needle electrodes are deployed into the uterine fibroid.

10. The method of claim 9 , wherein a plurality of needle electrodes are advanced forwardly and laterally relative to an access direction of the radiofrequency ablation device when the one or more needle electrodes are deployed into the uterine fibroid.

11. The method of claim 1 , wherein the ultrasonic imaging device is removably fixed relative to the radiofrequency ablation device when the ultrasonic imaging device and the radiofrequency ablation device are delivered into the uterine cavity.

12. The method of claim 11 , further comprising, prior to delivering the ultrasonic imaging device and the radiofrequency ablation device into the uterine cavity, coupling the ultrasonic imaging device and the radiofrequency ablation device together.

13. The method of claim 12 , wherein coupling the ultrasonic imaging device and the radiofrequency ablation device together comprises removably coupling a handle of the ultrasonic imaging device to a handle of the radiofrequency ablation device.

14. The method of claim 1 , further comprising, after delivering the radiofrequency energy to the one or more needle electrodes, uncoupling the ultrasonic imaging device from the radiofrequency ablation device.

15. The method of claim 14 , further comprising, after uncoupling the ultrasonic imaging device from the radiofrequency ablation device, disposing of the radiofrequency ablation device.

16. The method of claim 15 , further comprising, after uncoupling the ultrasonic imaging device from the radiofrequency ablation device, sterilizing the ultrasonic imaging device for reuse.

17. The method of claim 14 , wherein, after uncoupling the ultrasonic imaging device from the radiofrequency ablation device, the radiofrequency ablation device is disposable.

18. The method of claim 14 , wherein, after uncoupling the ultrasonic imaging device from the radiofrequency ablation device, the ultrasonic imaging device is sterilizable for reuse.

19. A method of treating a uterine fibroid, comprising;

delivering an ultrasonic imaging device and a radiofrequency ablation device coupled together into a uterine cavity, wherein the ultrasonic imaging device comprises an ultrasonic transducer and the radiofrequency ablation device comprises one or more needle electrodes;

deflecting a distal end of the ultrasonic imaging device to orient the ultrasonic transducer; and

deploying the one or more needle electrodes into a uterine fibroid while the ultrasonic imaging device provides a real time image of the uterine fibroid.

20. A method of treating a uterine fibroid, comprising;

delivering an ultrasonic imaging device and an ablation device coupled together into a uterine cavity, wherein the ultrasonic imaging device comprises an ultrasonic transducer and the ablation device comprises one or more needle electrodes;

deflecting a distal end of the ultrasonic imaging device to orient the ultrasonic transducer;

deploying the one or more needle electrodes into a uterine fibroid while the ultrasonic imaging device provides a real time image of the uterine fibroid; and

delivering energy to the one or more needle electrodes.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 070236/0154 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GYNESONICS, INC.
Reel/Frame 075455/0789 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Feb 14, 2025
From: GYNESONICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 070236/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2017
From: DECKMAN, ROBERT K.; GERBI, CRAIG; MUNROW, MICHAEL; GROSSMAN, JESSICA
To: GYNESONICS, INC.
Reel/Frame 042760/0079 →
Cited By (2)
US 12,414,813 US 12,514,432